Fiche centre
The Affiliated Hospital of Qingdao University
Qingdao — China
Essais liés10clinical trials
VilleQingdaolocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05152147
Essais cliniques associés
10| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| Zanidatamab | Parkinson | Phase 3 | NCT05152147 | HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers | ACTIVE_NOT_RECRUITING |
| [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis | Alzheimer | À vérifier | NCT07232459 | [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis | RECRUITING |
| Beta Amyloid PET/CT in Various Aβ-Related Disease | Alzheimer | À vérifier | NCT06725706 | Beta Amyloid PET/CT in Various Aβ-Related Disease | RECRUITING |
| Pan-Amyloid PET/CT in Various Amyloid-Related Disease | Alzheimer | À vérifier | NCT07130565 | Pan-Amyloid PET/CT in Various Amyloid-Related Disease | RECRUITING |
| [18F]NIDF PET Imaging in Tau-related Diseases | Alzheimer | À vérifier | NCT07306598 | [18F]NIDF PET Imaging in Tau-related Diseases | RECRUITING |
| Alpha-Synuclein PET/CT in Various α-Syn-Related Disease | Parkinson | À vérifier | NCT06949670 | Alpha-Synuclein PET/CT in Various α-Syn-Related Disease | RECRUITING |
| Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease | Parkinson | À vérifier | NCT07685873 | Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease | RECRUITING |
| PF-06821497 | Cancer | Phase 3 | NCT06629779 | A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. | RECRUITING |
| C-CAR168 | SEP | Phase 1 | NCT07676266 | A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy | NOT_YET_RECRUITING |